Navigation Links
Orthopaedics: Market Prospects & Global Competition
Date:7/20/2011

logics return to favour

M&A activity in the spine and orthobiologics sectors was subdued in 2009/10, but has returned with vigour in the first half of 2011. Facet Solutions, Applied Spine Technologies and Impliant were all snapped up for undisclosed sums between January and May, and activity culminated with an US$89 buy out of SeaSpine by Integra LifeSciences in May. This deal was, of course, dwarfed by Stryker's US$318 million investment in Orthovita in May 2011, which has to date been the year's major orthobiologics acquisition.

Joining the US$1 billion club?

Seven companies reported orthopaedic revenues exceeding US$1 billion in 2010. Together, these seven (Stryker, DePuy, Zimmer, Smith & Nephew, Biomet, Synthes and Medtronic) accounted for over 80% of the overall orthopaedic market. All but two have broad orthopaedic portfolios, the exceptions being Synthes and Medtronic who feature as orthopaedic market leaders by virtue of their dominance in their own specific niches, namely trauma and spinal. New future members are most likely to be DJO and Hanger Orthopaedic the specialists in rehabilitation and bracing services who are both fast approaching the US$1 billion revenue mark.

Orthopaedics: Market Prospects & Global Competition

List of companies in this report

aap Implantate

Alphatec Spine

Amedica

Anika Therapeutics

Artimplant

Ascension Orthopedics

Biomet

BioMimetic Therapeutics

BoneSupport

Cardo Medical

co.don

ConforMIS

Corin

DePuy

Disc Motion Technologies

DJO Global

Exactech

Globus Medical

Hanger Orthopedic

Inion

Integra LifeSciences

K2M

KFx Medical

Kuros Biosurgery

LDR Holdings

Life Spine

Mako Surgical

Mazor Robotics

Medicrea

Medtronic

NuVasive

Orthofix International

Orthovita'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Materialise Launches SurgiCase(R) Orthopaedics: A Comprehensive, Custom Solution That Assures Best Practices For The Orthopaedic Surgeon
2. Masimo to Report Second Quarter 2011 Financial Results after Market Close on August 9, 2011
3. DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting
4. North American External Defibrillator Market
5. European Medical Displays Markets
6. U.S. Nuclear Medicine and PET Imaging Systems Market
7. World Healthcare UPS Markets
8. Spanish Drug Companies Have New Support Option for the U.S. Market
9. Caliper Life Sciences to Ring The NASDAQ Stock Market Opening Bell on Tuesday, July 19
10. ReportsnReports - Rare Earth Elements Market, Healthcare Cold Chain Logistics Market & Pharmaceutical Market Reports
11. Neurosurgical Products Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently delivers ... to have it lead the wedding dress industry into the ... dresses for the global market. , “The CEO of VogueQueen ... focuses on continuing the goal of operational excellence and giving ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... annual revenues in the past three years. Today, the business ... , According to the sales manager of the company, this ... in 2015. This point can be reflected on the discounted ...
(Date:1/22/2015)... 2015 As interest in the value of ... momentum worldwide, Rev. Eric J. Hall , president and ... (HCCN), will be the keynote speaker on January 27 at ... health system. , The conference, “Hope and Resilience: Innovative and ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... discovered a potential new drug target for Multiple Sclerosis that ... new drug is developed. In the first phase ... of their brain cells, resulting in continuous cycles of inflammation ... of the disease, the inflammation isn,t as severe, but this ...
... By Alan Mozes HealthDay Reporter , WEDNESDAY, Oct. 26 ... made even walking a short distance an agony; a 20-year-old man ... ventilator; a woman with a potentially fatal buildup of a protein ... diagnose, let alone treat. And yet all of these ...
... , WEDNESDAY, Oct. 26 (HealthDay News) -- Moving ... music better, according to a new study. Researchers at ... for study participants, half of whom tapped on an electronic ... without tapping. The participants were asked whether the final ...
... , WEDNESDAY, Oct. 26 (HealthDay News) -- ... adults and teenagers in the United States, the U.S. ... as another National Prescription Drug Take-Back Day. ... to a 2009 survey from the U.S. Substance Abuse ...
... as comfortable with white light generated by diode lasers ... (LEDs), according to tests conceived at Sandia National Laboratories. ... generate light, but the simpler LED emits lights only ... forth internally before releasing it. The finding is ...
... estimate, half of Americans are confronting a civil legal problem at ... advice, or an advocate in civil court, they may lose a ... They may lose out in a divorce, or in a billing ... those services depends not on their need but where they live, ...
Cached Medicine News:Health News:Medical researchers ID potential new drug target that could stop debilitating effects of MS 2Health News:For Those With Mystery Illnesses, a 'Clinic of Last Resort' 2Health News:For Those With Mystery Illnesses, a 'Clinic of Last Resort' 3Health News:For Those With Mystery Illnesses, a 'Clinic of Last Resort' 4Health News:National Drug Take-Back Day Scheduled for Saturday 2Health News:High-quality white light produced by four-color laser source 2Health News:High-quality white light produced by four-color laser source 3Health News:Access to legal aid depends a lot on where you live, report says 2Health News:Access to legal aid depends a lot on where you live, report says 3
Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Medicine Products: